Characterization of high-level fluoroquinolone resistance in Escherichia coli O78:K80 isolated from turkeys

被引：35

作者：

Giraud, E ^{[1
]}

Leroy-Sétrin, S ^{[1
]}

Flaujac, G ^{[1
]}

Cloeckaert, A ^{[1
]}

Dho-Moulin, M ^{[1
]}

Chaslus-Dancla, E ^{[1
]}

机构：

[1] INRA, Ctr Rech Tours Nouzilly, Stn Pathol Aviare & Parasitol, F-37380 Monnaie, France

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2001年 / 47卷 / 03期

关键词：

D O I：

10.1093/jac/47.3.341

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Fluoroquinolone resistance was characterized in Escherichia coli O78:K80 isolated from diseased turkeys. The level of resistance to fluoroquinolones of the isolates appeared closely correlated with substitutions in GyrA and ParC, but not with the production of the AcrAB efflux pump. Among isolates highly resistant to ciprofloxacin (MIC 8 mg/L) and harbouring identical substitutions (two in GyrA and one in ParC), two close but distinguishable ribotypes were identified. This indicated that at least two independent selection events may have occurred.

引用

页码：341 / 343

页数：3

共 10 条

[1] Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV [J].

Breines, DM ;

Ouabdesselam, S ;

Ng, EY ;

Tankovic, J ;

Shah, S ;

Soussy, CJ ;

Hooper, DC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :175-179

[2]

CHERIFI A, 1994, J CLIN MICROBIOL, V32, P1197

[3]

*COM ANT SOC FRANC, 1998, PATHOL BIOL, V46, pR1

[4] Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals [J].

Everett, MJ ;

Jin, YF ;

Ricci, V ;

Piddock, LJV .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2380-2386

[5] Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field [J].

Giraud, E ;

Brisabois, A ;

Martel, JL ;

Chaslus-Dancla, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2131-2137

[6] Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium [J].

Giraud, E ;

Cloeckaert, A ;

Kerboeuf, D ;

Chaslus-Dancla, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (05) :1223-1228

[7] Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli [J].

Heisig, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :879-885

[8] Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli [J].

Kern, WV ;

Oethinger, M ;

Jellen-Ritter, AS ;

Levy, SB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :814-820

[9] Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump [J].

Oethinger, M ;

Kern, WV ;

Jellen-Ritter, AS ;

McMurry, LM ;

Levy, SB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :10-13

[10] QUINOLONE RESISTANCE-DETERMINING REGION IN THE DNA GYRASE GYRA GENE OF ESCHERICHIA-COLI [J].

YOSHIDA, H ;

BOGAKI, M ;

NAKAMURA, M ;

NAKAMURA, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) :1271-1272

← 1 →